Company intelligence / Profile preview

MiWEndo Solutions

Barcelona, Catalonia, Spainmiwendo.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

The MiWEndo system has demonstrated high sensitivity and specificity in preclinical models. A pilot human feasibility/safety study ("MiWEndo I", N=15) showed excellent results. An expanded clinical trial ("MiWEndo II", N=65) to further validate efficacy and safety is ongoing. Technical documentation has been submitted for CE certification.

Therapeutic areas: OncologyGastroenterology
Modalities: Device (specifically, electromagnetic/microwave-based diagnostic accessory)Non-pharmacological therapy (diagnostic support)
Industry: Medical Imaging

Partnerships

Universitat Pompeu Fabra (UPF)Hospital Clínic de Barcelona [HCB]Universitat Politècnica de Catalunya [UPC]Institució Catalana de Recerca i Estudis Avançats [ICREA]

Beyond the preview

Go deeper on MiWEndo Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MiWEndo Solutions.

Explore the full profile